NBNicolae Bodrug

Nicolae Bodrug

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicolae Bodrug has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatic Encephalopathy and Chronic Cerebrovascular Dysfunction (synthesis article)

    by Daniel Mocan, Francesca GhilașCu, Anastasia Comerzan, Diana Foiu, Diana Ciobanu, Daria Grigoreț, Adriana Botezatu, Nicolae Bodrug

    Hepatic encephalopathy (HE) is a frequent and disabling complication of liver cirrhosis and chronic liver failure. While traditionally attributed primarily to hyperammonemia, growing evidence indicates that HE results from the interaction of metabolic disturbances, systemic inflammation, intestinal dysbiosis, and cerebrovascular dysfunction, supporting its reconceptualization as a chronic brain disorder. A narrative review of the international literature published between 2000 and 2025 was conducted using PubMed/Medline, Journal of Hepatology, SpringerLink, and Google Scholar. Human studies relevant to the pathophysiology, diagnosis, and management of hepatic encephalopathy - including randomized controlled trials, observational studies, meta-analyses, and international guidelines - were included and synthesized qualitatively. Contemporary evidence supports an integrative gut-liver-brain model in which hyperammonemia acts synergistically with systemic inflammation, microbiome alterations, and blood-brain barrier dysfunction. These mechanisms converge to induce neuroinflammation, astrocytic dysfunction, and impaired cerebral blood flow autoregulation. Clinically, HE manifests across a broad cognitive, behavioral, and neuromotor spectrum, including minimal and covert forms associated with significant functional impairment. Cerebrovascular dysfunction appears to contribute to persistent cognitive deficits even after metabolic correction. Hepatic encephalopathy should be conceptualized as a metabolic-inflammatory-vascular brain disorder. While established therapies targeting ammonia and precipitating factors remain fundamental, emerging adjunctive approaches aimed at modulating inflammation, microbiome composition, and cerebral microcirculation warrant further investigation within rigorously designed clinical trials.

  • Open Access

    The Importance of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease (COPD)

    by Daniel Mocan, Francesca Ghilascu, Anastasia Comerzan, Anastasia Pascalova, Adriana Botezatu, Nicolae Bodrug

    Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. It is recognized as a systemic disorder, involving airflow limitation, persistent inflammation, oxidative stress, and vascular dysfunction. Pulmonary hypertension (PH) is a clinically relevant and often underdiagnosed complication, impacting prognosis, functional capacity, and survival. Recent evidence shows that PH in COPD can develop early, even in moderate disease, and is associated with pulmonary vascular remodeling, endothelial dysfunction, and systemic inflammation. Distinct phenotypes, including disproportionate PH-COPD forms, exhibit severe hemodynamic impairment and poor outcomes. This review critically synthesizes current literature on the epidemiology, pathophysiology, clinical relevance, and therapeutic strategies for PH-COPD. Emerging complementary approaches targeting oxidative stress, inflammation, and endothelial dysfunction, including medical ozone therapy, are also discussed.

  • Open Access

    Autohemoterapia hiperbară cu ozon în esofagul Barrett asociat infecției cu Helicobacter pylori: studiu clinic comparativ, controlat, longitudinal

    by Nicolae Bodrug, Viorel Istrate, Adriana Botezatu, Marcela Dragomir, Marcel Covalciuc, Daniel Mocan, Victoria Țurcan, Francesca GhilașCu

    Barrett’s Esophagus (BE) is a precancerous esophageal condition often associated with chronic gastroesophageal reflux, while the role of Helicobacter pylori (H. pylori) infection in its progression remains controversial. Oxidative stress and chronic inflammation are key factors in the advancement of esophageal metaplasia. In this context, hyperbaric ozone autohemotherapy (AHT-O₃) emerges as a promising adjuvant therapeutic option due to its antioxidant and immunomodulatory effects. This study included 60 patients with BE and active H. pylori infection, randomized into two equal groups: one treated with standard therapy combined with AHT-O₃, and one receiving standard therapy alone. Over a 12-month period, clinical, endoscopic, histological, and paraclinical evaluations were performed, including markers of oxidative stress, immunophenotyping, H. pylori infection status, CRP levels, GIQLI scores, and the dynamics of esophageal lesions. Ozone therapy led to a significant reduction in the oxidative stress marker malondialdehyde (MDA) and a notable increase in antioxidant enzymes (SOD, GPx, GST), indicating a restoration of redox balance. Concurrently, a significant increase in T-helper cells and a decrease in inflammatory T cells were observed, reflecting a favorable immune response. Parameters specific to H. pylori infection (IgA, IgG, fecal antigen) showed a more pronounced reduction in the ozone treatment group, indicating superior eradication efficiency. CRP levels decreased significantly, and GIQLI scores revealed a marked improvement in the quality of life. Endoscopic and histological assessments demonstrated a significantly higher rate of complete or partial regression of Barrett’s lesions in the ozone-treated group. Hyperbaric ozone autohemotherapy, when integrated into the standard therapeutic regimen, proved effective in counteracting oxidative stress, modulating immune responses, and significantly improving the clinical and histological status of patients with BE and H. pylori infection. These results support the use of this method as a complementary therapeutic strategy with added value in gastroenterology.

  • Open Access

    Patologia hepatică şi cea gastrointestinală în relație cu sindromul de fragilitate la pacienții vârstnici: studiu transversal

    by Ana Popescu, Gabriela Soric, Ana Popa, Adriana Botezatu, Nicolae Bodrug, Anatolie Negara

    The aging process involves a multitude of physiological age-related changes and the development of geriatric syndromes, including frailty syndrome (FS) - a complex geriatric syndrome characterized by increased vulnerability, commonly found in people over 65 years of age. Research on the various causes of FS demonstrates the multitude of factors involved in the evolution of frailty in the elderly, including liver and gastrointestinal pathology for this population group. A descriptive cross-sectional study included 613 patients admitted to Geriatric wards no. 1 and no. 2 of the Clinical Hospital for Recovery and Chronic Care in Chisinau, during the period 2020–2023. All patients were examined consecutively as they were admitted to the geriatric wards, with the patient’s consent to participate in the study, they were examined through a complex geriatric assessment (CGA), which includes clinical, laboratory exexamination and standardized geriatric assessment (scores). FS was established based on the Fried frailty screening criteria, the respondents were classified into robust, pre-frail and frail. The frail elderly group presented a higher share of hepatic and gastrointestinal pathology - 46.97%, followed by the pre-frail and robust elderly group, and comorbidity presents a particularity of the geriatric population. The most frequent hepato-gastric pathologies attested in the study group were chronic pancreatitis, followed by chronic gastritis and chronic hepatitis, representing a risk factor for the evolution of FS in the elderly.

  • Therapeutic and Immunological Effects of Systemic Ozone Therapy in Atrophic Gastritis with Active Helicobacter pylori Infection

    by Adriana Botezatu, Nicolae Bodrug, Gabriel-Ioan Prada, Marcel Covalciuc, Marcela Dragomir, Leonid Chislaru, Victoria Turcan, Daniel Mocan, Francesca Ghilascu

    Atrophic gastritis is a precancerous lesion frequently associated with active Helicobacter pylori infection, representing a major risk factor for gastric cancer. The present controlled and longitudinal study evaluated the efficacy of ozone hyperbaric autohemotherapy (AHT-O₃) as an adjuvant treatment. The group of 60 patients was divided into two equal groups: standard treatment and standard treatment + AHT-O₃. At 12 months, the H. pylori eradication rate was 96% in the AHT-O₃ group, compared to 73% in the control group. Also, ozone-treated patients showed a decrease in malondialdehyde (from 4.5 to 2.2 nmol/ml) and an increase in SOD (from 150 to 210 U/ml). Immunologically, the proportion of T helper lymphocytes increased by 14%, and mucosal inflammation was reduced. Endoscopically, 47% of ozone-treated patients showed normalization of the gastric mucosa. The therapy was well tolerated, without adverse reactions. The results support the integration of ozone therapy into the complex management of HP-positive atrophic gastritis, especially in cases resistant to standard treatment.

  • Helicobacter pylori Infection - Associated Intestinal Metaplasia: A Comparative, Controlled, Longitudinal Clinical Study on the Efficacy of Hyperbaric Ozone Autohemotherapy

    by Adriana Botezatu, Nicolae Bodrug, Gabriel-Ioan Prada, Marcel Covalciuc, Francesca Ghilascu, Daniel Mocan, Victoria Turcan

    Gastric intestinal metaplasia is a precancerous lesion frequently associated with chronic H.pylori infection, representing a key stage in the gastric carcinogenesis cascade. Although bacterial eradication reduces the risk of progression to gastric adenocarcinoma, the efficacy of standard treatment in reversing intestinal metaplasia remains limited, particularly in extensive or incomplete forms. In this context, hyperbaric ozone autohemotherapy (AHT-O₃) is proposed as a therapeutic adjuvant with antioxidant, anti-inflammatory and immunomodulatory potential. This comparative, controlled and longitudinal clinical study evaluated the efficacy of AHT-O₃ combined with conventional therapy in 60 adult patients diagnosed with intestinal metaplasia and active H.pylori infection. The AHT-O₃-treated group showed a significant reduction in malondialdehyde (MDA) levels and an increase in the activity of antioxidant enzymes (SOD, GPx, GST), compared to the control group (p less than 0.001). Additionally, a stimulation of T-helper lymphocytes and a decrease in pro-inflammatory lymphocytes were observed, indicating a robust immunoregulatory effect. The H.pylori eradication rate was higher in the ozone group (84% vs. 60%, p = 0.04), with a significantly greater decrease in IgA and IgG titers (p less than 0.01). Endoscopic and histological evaluation after 12 months showed an increased rate of complete and partial regression of intestinal metaplasia lesions and a marked reduction in gastric mucosal inflammation. The GIQLI score indicated a significant improvement in quality of life in the ozone-treated group. These results support the inclusion of AHT-O₃ as a viable complementary option in the therapeutic strategy for H.pylori-associated intestinal metaplasia, with a positive impact on the clinical, biochemical, and histological progression of the condition.

  • Open Access

    Patologia hepatică şi cea gastrointestinală în relație cu sindromul de fragilitate la pacienții vârstnici: studiu transversal

    by Ana Popescu, Gabriela Soric, Ana Popa, Adriana Botezatu, Nicolae Bodrug, Anatolie Negara

    The aging process involves a multitude of physiological agerelated changes and the development of geriatric syndromes, including frailty syndrome (FS) - a complex geriatric syndrome characterized by increased vulnerability, commonly found in people over 65 years of age. Research on the various causes of FS demonstrates the multitude of factors involved in the evolution of frailty in the elderly, including liver and gastrointestinal pathology for this population group. A descriptive cross-sectional study included 613 patients admitted to Geriatric wards no. 1 and no. 2 of the Clinical Hospital for Recovery and Chronic Care in Chisinau, during the period 2020–2023. All patients were examined consecutively as they were admitted to the geriatric wards, with the patient’s consent to participate in the study, they were examined through a complex geriatric assessment (CGA), which includes clinical, laboratory examination and standardized geriatric assessment (scores). FS was established based on the Fried frailty screening criteria, the respondents were classified into robust, pre-frail and frail. The frail elderly group presented a higher share of hepatic and gastrointestinal pathology - 46.97%, followed by the pre-frail and robust elderly group, and comorbidity presents a particularity of the geriatric population. The most frequent hepato-gastric pathologies attested in the study group were chronic pancreatitis, followed by chronic gastritis and chronic hepatitis, representing a risk factor for the evolution of FS in the elderly.

  • The impact of secondary pulmonary hypertension in elderly patients with chronic obstructive pulmonary disease

    by Ecaterina Luca, Nicolae Bodrug

    Chronic obstructive pulmonary disease (COPD) is considered an important disease in the structure of morbidity and mortality and a rising public health problem with increasing global age prevalence. Exacerbation of COPD in the elderly has a significant negative impact on the clinical and paraclinical picture, daily activity capacity, and quality of life. The need for correct diagnostic management is dictated by the severity of the pathology in the elderly and the high frequency of cardiac complications. Studying the clinical-paraclinical picture and the diagnostic capacity of natriuretic peptides in COPD patients with cardiovascular complications was the aim of the present research. Material and methods. We conducted an analytical, observational, case-control study with the use of modern research methods. The study included 194 elderly patients (≥ 65 years old) divided into two study groups: those with only COPD (COPD group) and those with associated pulmonary hypertension (PHCOPD group). Patients underwent clinical, paraclinical, and functional investigation methods with subsequent mathematical-statistical data processing. Results. The study groups were similar according to socio-demographic data. The clinical assessment revealed that PHCOPD patients had, in comparison with COPD patients, statistically significantly more frequent and severe complaints. The objective examination determined that in PHCOPD patients, the values of the objective examination indices were much more affected than in the COPD group. At the complex geriatric assessment, the COPD group of patients shows a lower degree of dependence and less cognitive impairment. The multidimensional assessment of COPD reflected more severe impairment according to the CAT, SGRQ, CCQ, mMRC, BODE questionnaires, and 6MWT test in the PHCOPD group compared to the COPD group. Spirographic, radiographic, ultrasonographic, and echocardiographic evaluations correlated with age, inflammatory syndrome, and natriuretic peptide level. Conclusions. The PHCOPD group patients present a clinical picture, exercise capacity, objective data, complex geriatric assessment scores, and a multidimensional assessment of COPD that is statistically more frequent and severely affected compared to the COPD group. The impact of hemodynamic disturbances in COPD could be confirmed by the correlation of paraclinical data, such as the inflammatory response syndrome, increased natriuretic peptides, echocardiography data, and indices of internal organ ultrasound examination.


  • Open Access

    The frequency of pulmonary hypertension in chronic obstructive pulmonary disease of geriatric patients: a narrative literature review

    by Ecaterina Luca, Nicolae Bodrug

    Background: Pulmonary hypertension (PH) is a serious complication with complex pathogenesis in the natural history of chronic obstructive pulmonary disease COPD, with a progressively increasing frequency with a meanwhile decreasing in functional capacity. Purpose: Assessment of the incidence, pathogenesis, peculiarities, and complications of PH in COPD in geriatric population worldwide. Methods: We performed an analysis of randomized, retrospective, and prospective clinical, case-control and observational studies, published at the international level, according to the subject studied and target population. Four hundred ninety-seven full articles were identified after the search through engine Google Search and databases PubMed, Hinari, SpringerLink, and Scopus (Elsevier) according to the keywords and subsequent filters. Results: Depending on various factors, like the population examined, the definition used for mPAP (mPAP> 20 mm Hg or ≥25 mm Hg), the severity of the lung disease, and the method of measuring PAP, a varied incidence of COPD patients with PH complication was discovered, namely 10–91%. PH prevalence increases with the COPD severity. The presence of PH is associated with acute exacerbations of COPD, reduced survival, and increasing expenses for healthcare programs. Mild to moderate levels of PH (mPAP 25–34 mm Hg) are relatively common in COPD and usually are associated with severe airflow obstruction or parenchymal destruction. Only a minority of patients (1–5%) have severe PH (mPAP ≥35 mm Hg). Conclusions: Diagnosis of PH in COPD is difficult, especially in a mild form, and requires a clinical approach associated with a comprehensive set of investigations for confirming the etiology, evaluation of the functional and hemodynamical impairment severity, and important factors in the appropriate treatment election.


  • Open Access

    Natriuretic peptides in elderly patients with chronic obstructive pulmonary disease

    by Bodrug Nicolae, Luca Ecaterina

    Background: Natriuretic peptides (NPs) are considered a useful tool for diagnosing the cardiac or pulmonary origin of acute dyspnea in the emergency department. The aim of this study was to evaluate NP in elderly patients with chronic obstructive pulmonary disease (COPD). Materials and methods: In the PubMed and Hinari databases, we identified 465 comprehensive articles in English, published in the years 1990–2021, which provided information on natriuretic peptides in elderly patients with COPD. The final bibliography contains 49 relevant sources. Results: NP, specially BNP/NT-proBNP values are frequently elevated in patients with COPD, reflecting three complex aspects of the interrelated cardio-pulmonary continuum: (1) left ventricular systolic and diastolic dysfunction, (2) pulmonary vascular and right heart remodeling, (3) global cardiovascular risk and comorbidities. The additional increase in BNP/NT-proBNP values during acute exacerbation of COPD is probably a marker for both, acute estate of COPD and varying degrees of underlying cardiopulmonary disease. The results of the studies suggest the role of natriuretic peptides as relevant prognostic biomarkers not only for patients with cardiovascular disease, but also for patients with chronic obstructive pulmonary disease, which has an important clinical implication. The determination of these biomarkers in patients with chronic obstructive pulmonary disease allows stratification for prognosis: it is able to select a subgroup of patients at higher risk, which requires increased attention and optimization of treatment. Conclusion: NPs, especially BNP/NT-proBNP are relevant prognostic biomarkers not only for patients with cardiovascular disease, but also for patients with COPD, acute exacerbations and haemodynamic disorders like PH and cor pulmonale. Estimating BNP/NT-proBNP in COPD patients has an important clinical implication: it allows the selection of a subgroup of patients at higher risk, which requires increased attention and treatment optimization.